Publication | Open Access

Predictive factors of mortality in patients treated with tocilizumab for acute respiratory distress syndrome related to coronavirus disease 2019 (COVID-19)

Acute Lung InjuryPredictive FactorsCovid-19 PandemicRespiratory InfectionInfectious Respiratory DiseaseDisease 2019Covid-19 EpidemiologyAcute MedicineMedicineCovid-19